 EXTON, Pa., Jan. 20, 2021 PRNewswire -- Two 2020 European Medical Agency EMA approvals, Takedas Entyvio SC and Celltrion Healthcares infliximab biosimilar, Remsima SC, have captured notable shares among EU5 IBD patients, according to Spherixs recent report, RealTime DynamixTM:... 